Cutaneous malignant melanoma: Current views on pathogenesis, diagnosis, and surgical management

Yehuda G. Adam, Gershon Efron

Research output: Contribution to journalArticle

Abstract

Reliable cancer statistics reveal an unexplained increase in the incidence and rate of death from melanoma. Increased exposure to ultraviolet light does not seem to be a factor. Hormones may affect the incidence but do not influence survival. The recognition of the biologic evolution of different types of melanomas and the prognostic value of microstaging has had a major impact on the surgical management of cutaneous melanomas. Currently adequate excision is the only available curative treatment for melanoma and is most effective if performed on an early lesion. The extent of the excision should depend on the level of invasion and the bulk and location of the lesion. When clinically involved, dissection of the regional lymph nodes should be performed. The value of prophylactic node dissection of clinically uninvolved regional lymph nodes is unknown. Because of the low probability of regional lymph node involvement in thin lesions (less than 0.75 mm), prophylactic node dissection is not warranted. In contrast, there is a much higher incidence of spread to the regional lymph nodes reported in melanomas found to be thicker than 0.75 mm by microstaging. Prophylactic node dissection is probably worthwhile for these patients. Improved prospective randomized studies are needed to evaluate and determine the effectiveness of the various treatments that are being recommended.

Original languageEnglish (US)
Pages (from-to)481-494
Number of pages14
JournalSurgery
Volume93
Issue number4
StatePublished - 1983

Fingerprint

Melanoma
Dissection
Lymph Nodes
Incidence
Ultraviolet Rays
Lymph Node Excision
Cutaneous Malignant Melanoma
Hormones
Prospective Studies
Skin
Survival
Mortality
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Cutaneous malignant melanoma : Current views on pathogenesis, diagnosis, and surgical management. / Adam, Yehuda G.; Efron, Gershon.

In: Surgery, Vol. 93, No. 4, 1983, p. 481-494.

Research output: Contribution to journalArticle

Adam, Yehuda G. ; Efron, Gershon. / Cutaneous malignant melanoma : Current views on pathogenesis, diagnosis, and surgical management. In: Surgery. 1983 ; Vol. 93, No. 4. pp. 481-494.
@article{47b3b56a67d64eab91ac0c82f3293ce5,
title = "Cutaneous malignant melanoma: Current views on pathogenesis, diagnosis, and surgical management",
abstract = "Reliable cancer statistics reveal an unexplained increase in the incidence and rate of death from melanoma. Increased exposure to ultraviolet light does not seem to be a factor. Hormones may affect the incidence but do not influence survival. The recognition of the biologic evolution of different types of melanomas and the prognostic value of microstaging has had a major impact on the surgical management of cutaneous melanomas. Currently adequate excision is the only available curative treatment for melanoma and is most effective if performed on an early lesion. The extent of the excision should depend on the level of invasion and the bulk and location of the lesion. When clinically involved, dissection of the regional lymph nodes should be performed. The value of prophylactic node dissection of clinically uninvolved regional lymph nodes is unknown. Because of the low probability of regional lymph node involvement in thin lesions (less than 0.75 mm), prophylactic node dissection is not warranted. In contrast, there is a much higher incidence of spread to the regional lymph nodes reported in melanomas found to be thicker than 0.75 mm by microstaging. Prophylactic node dissection is probably worthwhile for these patients. Improved prospective randomized studies are needed to evaluate and determine the effectiveness of the various treatments that are being recommended.",
author = "Adam, {Yehuda G.} and Gershon Efron",
year = "1983",
language = "English (US)",
volume = "93",
pages = "481--494",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Cutaneous malignant melanoma

T2 - Current views on pathogenesis, diagnosis, and surgical management

AU - Adam, Yehuda G.

AU - Efron, Gershon

PY - 1983

Y1 - 1983

N2 - Reliable cancer statistics reveal an unexplained increase in the incidence and rate of death from melanoma. Increased exposure to ultraviolet light does not seem to be a factor. Hormones may affect the incidence but do not influence survival. The recognition of the biologic evolution of different types of melanomas and the prognostic value of microstaging has had a major impact on the surgical management of cutaneous melanomas. Currently adequate excision is the only available curative treatment for melanoma and is most effective if performed on an early lesion. The extent of the excision should depend on the level of invasion and the bulk and location of the lesion. When clinically involved, dissection of the regional lymph nodes should be performed. The value of prophylactic node dissection of clinically uninvolved regional lymph nodes is unknown. Because of the low probability of regional lymph node involvement in thin lesions (less than 0.75 mm), prophylactic node dissection is not warranted. In contrast, there is a much higher incidence of spread to the regional lymph nodes reported in melanomas found to be thicker than 0.75 mm by microstaging. Prophylactic node dissection is probably worthwhile for these patients. Improved prospective randomized studies are needed to evaluate and determine the effectiveness of the various treatments that are being recommended.

AB - Reliable cancer statistics reveal an unexplained increase in the incidence and rate of death from melanoma. Increased exposure to ultraviolet light does not seem to be a factor. Hormones may affect the incidence but do not influence survival. The recognition of the biologic evolution of different types of melanomas and the prognostic value of microstaging has had a major impact on the surgical management of cutaneous melanomas. Currently adequate excision is the only available curative treatment for melanoma and is most effective if performed on an early lesion. The extent of the excision should depend on the level of invasion and the bulk and location of the lesion. When clinically involved, dissection of the regional lymph nodes should be performed. The value of prophylactic node dissection of clinically uninvolved regional lymph nodes is unknown. Because of the low probability of regional lymph node involvement in thin lesions (less than 0.75 mm), prophylactic node dissection is not warranted. In contrast, there is a much higher incidence of spread to the regional lymph nodes reported in melanomas found to be thicker than 0.75 mm by microstaging. Prophylactic node dissection is probably worthwhile for these patients. Improved prospective randomized studies are needed to evaluate and determine the effectiveness of the various treatments that are being recommended.

UR - http://www.scopus.com/inward/record.url?scp=0020534087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020534087&partnerID=8YFLogxK

M3 - Article

C2 - 6340230

AN - SCOPUS:0020534087

VL - 93

SP - 481

EP - 494

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 4

ER -